154 related articles for article (PubMed ID: 38386612)
1. Comparison of Behavioral Effects of GABAergic Low- and High-Efficacy Neuroactive Steroids in the Zebrafish Larvae Assay.
Germann AL; Xu Y; Covey DF; Evers AS; Akk G
ACS Chem Neurosci; 2024 Mar; 15(5):909-915. PubMed ID: 38386612
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific hypnotic effects of the neuroactive steroid (3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile are mediated by peripheral metabolism into an active hypnotic steroid.
Manzella FM; Cabrera OH; Wilkey D; Fine-Raquet B; Klawitter J; Krishnan K; Covey DF; Jevtovic-Todorovic V; Todorovic SM
Br J Anaesth; 2023 Feb; 130(2):154-164. PubMed ID: 36428160
[TBL] [Abstract][Full Text] [Related]
3. Neurosteroid modulation of recombinant rat alpha5beta2gamma2L and alpha1beta2gamma2L GABA(A) receptors in Xenopus oocyte.
Rahman M; Lindblad C; Johansson IM; Bäckström T; Wang MD
Eur J Pharmacol; 2006 Oct; 547(1-3):37-44. PubMed ID: 16934248
[TBL] [Abstract][Full Text] [Related]
4. Multiple structural features of steroids mediate subtype-selective effects on human alpha4beta3delta GABAA receptors.
Pillai GV; Smith AJ; Hunt PA; Simpson PB
Biochem Pharmacol; 2004 Sep; 68(5):819-31. PubMed ID: 15294445
[TBL] [Abstract][Full Text] [Related]
5. Partial agonism by 3alpha,21-dihydroxy-5beta-pregnan-20-one at the gamma-aminobutyric acidA receptor neurosteroid site.
Xue BG; Whittemore ER; Park CH; Woodward RM; Lan NC; Gee KW
J Pharmacol Exp Ther; 1997 Jun; 281(3):1095-101. PubMed ID: 9190841
[TBL] [Abstract][Full Text] [Related]
6. New evidence that both T-type calcium channels and GABAA channels are responsible for the potent peripheral analgesic effects of 5alpha-reduced neuroactive steroids.
Pathirathna S; Brimelow BC; Jagodic MM; Krishnan K; Jiang X; Zorumski CF; Mennerick S; Covey DF; Todorovic SM; Jevtovic-Todorovic V
Pain; 2005 Apr; 114(3):429-443. PubMed ID: 15777868
[TBL] [Abstract][Full Text] [Related]
7. Neuroactive steroids have multiple actions to potentiate GABAA receptors.
Akk G; Bracamontes JR; Covey DF; Evers A; Dao T; Steinbach JH
J Physiol; 2004 Jul; 558(Pt 1):59-74. PubMed ID: 15146041
[TBL] [Abstract][Full Text] [Related]
8. A synthetic 18-norsteroid distinguishes between two neuroactive steroid binding sites on GABAA receptors.
Evers AS; Chen ZW; Manion BD; Han M; Jiang X; Darbandi-Tonkabon R; Kable T; Bracamontes J; Zorumski CF; Mennerick S; Steinbach JH; Covey DF
J Pharmacol Exp Ther; 2010 May; 333(2):404-13. PubMed ID: 20124410
[TBL] [Abstract][Full Text] [Related]
9. Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms.
Maitra R; Reynolds JN
Can J Physiol Pharmacol; 1998 Sep; 76(9):909-20. PubMed ID: 10066142
[TBL] [Abstract][Full Text] [Related]
10. The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptors.
Li P; Bracamontes JR; Manion BD; Mennerick S; Steinbach JH; Evers AS; Akk G
Br J Pharmacol; 2014 Dec; 171(23):5446-57. PubMed ID: 25117207
[TBL] [Abstract][Full Text] [Related]
11. Substituted 3beta-phenylethynyl derivatives of 3alpha-hydroxy-5alpha-pregnan-20-one: remarkably potent neuroactive steroid modulators of gamma-aminobutyric acidA receptors.
Hawkinson JE; Acosta-Burruel M; Yang KC; Hogenkamp DJ; Chen JS; Lan NC; Drewe JA; Whittemore ER; Woodward RM; Carter RB; Upasani RB
J Pharmacol Exp Ther; 1998 Oct; 287(1):198-207. PubMed ID: 9765338
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum.
Porcu P; O'Buckley TK; Alward SE; Marx CE; Shampine LJ; Girdler SS; Morrow AL
Steroids; 2009; 74(4-5):463-73. PubMed ID: 19171160
[TBL] [Abstract][Full Text] [Related]
13. Neurosteroid modulation of recombinant and synaptic GABAA receptors.
Lambert JJ; Harney SC; Belelli D; Peters JA
Int Rev Neurobiol; 2001; 46():177-205. PubMed ID: 11599300
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen and progesterone on neuroactive steroids and cytokines in patients with suicidality.
Barone JC; Wenzel E; Alluri V; Moriarity D; Pinna G; Walsh E; Rubinow DR; Morrow AL; Eisenlohr-Moul TA
Psychoneuroendocrinology; 2023 Nov; 157():106359. PubMed ID: 37611527
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.
Hirani K; Sharma AN; Jain NS; Ugale RR; Chopde CT
Psychopharmacology (Berl); 2005 Jul; 180(2):267-78. PubMed ID: 15719223
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of neurosteroid modulation of native gamma-aminobutyric acid receptors by (3alpha,5alpha)-17-phenylandrost-16-en-3-ol.
Kelley SP; Alan JK; O'Buckley TK; Mennerick S; Krishnan K; Covey DF; Leslie Morrow A
Eur J Pharmacol; 2007 Oct; 572(2-3):94-101. PubMed ID: 17658511
[TBL] [Abstract][Full Text] [Related]
17. Effects on gamma-aminobutyric acid (GABA)(A) receptors of a neuroactive steroid that negatively modulates glutamate neurotransmission and augments GABA neurotransmission.
Mennerick S; Zeng CM; Benz A; Shen W; Izumi Y; Evers AS; Covey DF; Zorumski CF
Mol Pharmacol; 2001 Oct; 60(4):732-41. PubMed ID: 11562435
[TBL] [Abstract][Full Text] [Related]
18. Modulation of GABAA receptor-mediated IPSCs by neuroactive steroids in a rat hypothalamo-hypophyseal coculture model.
Poisbeau P; Feltz P; Schlichter R
J Physiol; 1997 Apr; 500 ( Pt 2)(Pt 2):475-85. PubMed ID: 9147331
[TBL] [Abstract][Full Text] [Related]
19. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
Rupprecht R
Psychoneuroendocrinology; 2003 Feb; 28(2):139-68. PubMed ID: 12510009
[TBL] [Abstract][Full Text] [Related]
20. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
